Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 1696 AL 1710

Studying the Pathophysiology of Parkinson's Disease Using Zebrafish

Barnhill LM, Murata H, Bronstein JM.

Biomedicines. 2020 Jul 7;8(7):197. doi: 10.3390/biomedicines8070197.

Epigenetic Basis of Lead-Induced Neurological Disorders

Wang T, Zhang J, Xu Y.

Int J Environ Res Public Health. 2020 Jul 7;17(13):4878. doi: 10.3390/ijerph17134878.

A Novel Mutation of PARK-2 Gene in a Patient with Early-onset Parkinson's Disease

Alafifi T, Bakhsh ARA, Elbashari M, Abouelnaga MEH, Eldimllawi AM.

Oman Med J. 2020 Jun 30;35(3):e140. doi: 10.5001/omj.2020.58. eCollection 2020 May.

Can skin biopsy differentiate Parkinson disease from multiple system atrophy? And other updates on recent autonomic research

Miglis MG, Muppidi S.

Clin Auton Res. 2020 Aug;30(4):287-289. doi: 10.1007/s10286-020-00712-2. Epub 2020 Jul 9.

Safinamide in the treatment of Parkinson's disease

Müller T.

Neurodegener Dis Manag. 2020 Aug;10(4):195-204. doi: 10.2217/nmt-2020-0017. Epub 2020 Jul 10.

Association of the serum microRNA-29 family with cognitive impairment in Parkinson's disease

Han L, Tang Y, Bai X, Liang X, Fan Y, Shen Y, Huang F, Wang J.

Aging (Albany NY). 2020 Jul 9;12(13):13518-13528. doi: 10.18632/aging.103458. Epub 2020 Jul 9.

Neurogenic Orthostatic Hypotension: An Underrecognized Complication of Parkinson Disease

Sin MK, Khemani P.

J Neurosci Nurs. 2020 Oct;52(5):230-233. doi: 10.1097/JNN.0000000000000528.

Purine molecules in Parkinson's disease: Analytical techniques and clinical implications

Von Seggern M, Szarowicz C, Swanson M, Cavotta S, Pike ST, Lamberts JT.

Neurochem Int. 2020 Oct;139:104793. doi: 10.1016/j.neuint.2020.104793. Epub 2020 Jul 7.

Role of Helicobacters in Neuropsychiatric Disease: A Systematic Review in Idiopathic Parkinsonism

Tucker RM, Augustin AD, Hayee BH, Bjarnason I, Taylor D, Weller C, Charlett A, Dobbs SM, Dobbs RJ.

J Clin Med. 2020 Jul 8;9(7):2159. doi: 10.3390/jcm9072159.

The Role of Oxidative Stress in Parkinson's Disease

Chang KH, Chen CM.

Antioxidants (Basel). 2020 Jul 8;9(7):597. doi: 10.3390/antiox9070597.

Discrete changes in brain volume after deep brain stimulation in patients with Parkinson's disease

Kern DS, Uy D, Rhoades R, Ojemann S, Abosch A, Thompson JA.

J Neurol Neurosurg Psychiatry. 2020 Sep;91(9):928-937. doi: 10.1136/jnnp-2019-322688. Epub 2020 Jul 10.

Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease

Zach H, Dirkx MF, Roth D, Pasman JW, Bloem BR, Helmich RC.

Neurology. 2020 Sep 15;95(11):e1461-e1470. doi: 10.1212/WNL.0000000000010316. Epub 2020 Jul 10.

The Choice Between Advanced Therapies for Parkinson's Disease Patients: Why, What, and When?

Dijk JM, Espay AJ, Katzenschlager R, de Bie RMA.

J Parkinsons Dis. 2020;10(s1):S65-S73. doi: 10.3233/JPD-202104.

What People with Parkinson's Disease Want

Andrejack J, Mathur S.

J Parkinsons Dis. 2020;10(s1):S5-S10. doi: 10.3233/JPD-202107.

Preventive treatments to slow substantia nigra damage and Parkinson's disease progression: A critical perspective review

Bjørklund G, Dadar M, Anderson G, Chirumbolo S, Maes M.

Pharmacol Res. 2020 Nov;161:105065. doi: 10.1016/j.phrs.2020.105065. Epub 2020 Jul 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias